Delaware
(State
or Other Jurisdiction of Incorporation or Organization)
|
5615
Scotts Valley Drive, Suite 110
Scotts
Valley, California 95066
(831) 438-8200
|
77-0390628
(I.R.S.
Employer
Identification
Number)
|
Large
accelerated filer o
|
Accelerated
filer þ
|
Non-accelerated
filer o
|
Smaller
reporting company o
|
Title
of Each Class of Shares To Be Registered
|
Amount
to be Registered (1)
|
Proposed
Maximum Offering Price Per Unit
|
Proposed
Maximum Aggregate Offering Price
|
Amount
of Registration Fee
|
Common
Stock, par value $0.0001 per share
|
10,427,888
|
$1.969(2)
|
$20,532,511.47(2)
|
$1,550.70(3)
|
(1)
|
The
shares of common stock being registered hereunder include (i) 2,380,942
shares of common stock being registered for resale by certain stockholders
of the Registrant, and (ii) (x) 3,246,959 shares of common stock issuable
upon exercise of the Series I Warrants, (y) up to 2,419,045 shares of
common stock issuable upon exercise of the Series II Warrants, and (z)
2,380,942 shares of common stock issuable upon exercise of the Series III
Warrants, being registered for resale by certain warrant holders of the
Registrant. Pursuant to Rule 416(a) under the Securities Act, this
registration statement also covers such number of additional shares of
common stock, of a currently indeterminable amount, as may from time to
time become issuable by reason of stock splits, stock dividends or similar
transactions.
|
(2)
|
Estimated
solely for the purpose of calculating the registration fee pursuant to
Rule 457(c) under the Securities Act, based upon the average of the high
and low sales prices of the registrant’s common stock, as reported on the
NYSE Amex on November 5, 2009.
|
(3)
|
The registrant previously filed the Registration Statement
on Form S-3 (333-162145) covering the offering of 10,427,850 shares of
common stock. The previously paid registration fee of $1,550.70
covers the 10,427,888 shares of common stock being offered pursuant to
this Amendment No.1 to the Registration Statement on Form S-3
(333-162145).
|
ABOUT
THIS PROSPECTUS
|
ii
|
SUMMARY
|
1
|
RISK
FACTORS
|
6
|
USE
OF PROCEEDS
|
21
|
DIVIDEND
POLICY
|
21
|
THE TRANSACTION
|
21
|
SELLING
SECURITY HOLDERS
|
21
|
PLAN
OF DISTRIBUTION
|
25
|
DESCRIPTION
OF SECURITIES
|
27
|
LEGAL
MATTERS
|
29
|
EXPERTS
|
29
|
WHERE
YOU CAN FIND MORE INFORMATION
|
30
|
CERTAIN
DOCUMENTS INCORPORATED BY REFERENCE
|
30
|
Background
|
We
have filed this registration statement on Form S-3 to register shares of
our common stock and shares of our common stock underlying the Series I
Warrants, the Series II Warrants and the Series III Warrants issued in a
private placement transaction on September 11, 2009.
|
Securities
Offered Pursuant to this Prospectus
|
2,380,942
shares of common stock and an aggregate of 8,046,946 shares of common
stock underlying the warrants issued in the private placement transaction,
comprised of:
-
3,246,959 shares of common stock underlying the Series I Warrants with an
exercise price of $3.93 per share, of which (i) up to 627,923 shares of
common stock are issuable pursuant to certain anti-dilution adjustment
provisions in the Series I Warrants, and (ii) 238,094 shares of common
stock are issuable pursuant to a warrant issued to Dawson James
Securities, Inc., the placement agent in connection with the private
placement transaction;
-
2,419,045 shares of common stock underlying the Series II Warrants
exercisable on a cashless basis with an exercise price of $0.01 per share;
and
-
2,380,942 shares of common stock underlying the Series III Warrants with
an exercise price of $2.52 per share.
|
Transaction
Proceeds
|
Assuming
the cash exercise of the Series I and Series III Warrants, and including
the cash proceeds received by us from the sale of common stock issued to
the investors at the closing, we will receive gross proceeds of
approximately $22,292,759 from this transaction. We anticipate
that all net proceeds obtained by us from the transaction will be used for
our working capital purposes.
Any
proceeds from the sale of the securities offered by this prospectus will
be received by the selling security holders for their own account, and we
will not receive any proceeds from the sale of any securities offered by
this prospectus.
|
NYSE
Amex symbol for our common stock
|
Our
common stock is listed on the NYSE Amex under the symbol
“VHC”.
|
|
·
|
Automatic and seamless to the
user. After a one-time registration, users connect
securely on a “zero-click” or “single-click”
basis.
|
|
·
|
Secure data
communications. Users create secure networks with people
they trust and communicate over a secure
channel.
|
|
·
|
Control of data at all
times. Users can secure and customize their unified
communication and collaboration applications such as file sharing and
remote desktop with policy-based access and secure presence
information.
|
|
·
|
Authenticated
users. Users know they are communicating with
authenticated users with secure domain
names.
|
|
·
|
Application-agnostic
technology. Our solution provides security at the IP
layer of the network by using patented techniques for automated DNS lookup
mechanisms to make connections between secure domain names, thereby
obviating the need to provide application specific
security.
|
|
·
|
Unique patented
technology. We are focused on developing innovative
technology for securing real-time communications over the Internet, and
establishing the exclusive secure domain name registry in the United
States and other key markets around the world. Our unique solutions
combine industry standard encryption methods and communication protocols
with our patented techniques for automated DNS lookup mechanisms. Our
technology and patented approach enables users to create a secure
communication link by generating secure domain names. We have a strong
portfolio comprised of 11 patents in the United States and eight
international patents, as well as several pending U.S. and foreign
patent applications. Our portfolio includes patents and pending patent
applications in the United States and other key markets that support our
secure domain name registry service for the
Internet.
|
|
·
|
Scalable licensing business
model. Our intellectual property portfolio is the
foundation of our business model. We are actively engaged in
commercializing our intellectual property portfolio by pursuing licensing
agreements with OEMs, service providers and system integrators within the
IP-telephony, mobility, fixed-mobile convergence and unified
communications end-markets. We have engaged ipCapital Group to accelerate
our patent and technology licensing program with customers and to expand
the depth of our intellectual property portfolio, and we are actively
pursuing our first licensing agreements. We believe that our licensing
business model is highly scalable and has the potential to generate strong
margins once we achieve significant revenue
growth.
|
|
·
|
Highly experienced research and
development team. Our
research and development team is comprised of nationally recognized
network security and encryption technology scientists and experts that
have worked together as a team for over ten years and, collectively, have
over 120 years of experience in the field. During their careers, this
team has developed several cutting-edge technologies for
U.S. national defense, intelligence and civilian agencies, many of
which remain critical to our national security today. Prior to joining
VirnetX, our team worked for SAIC during which time they invented the
technology that is the foundation of our patent portfolio, technology, and
software. Based on the collective knowledge and experience of our
development team, we believe that we have one of the most experienced and
sophisticated groups of security experts researching vulnerability and
threats to real-time communication over the Internet and developing
solutions to mitigate these
problems.
|
|
·
|
Implement
a patent and technology licensing program to commercialize our
intellectual property, including our GABRIEL Connection Technologytm.
|
|
·
|
Establish
VirnetX as the exclusive universal registry of secure domain names and to
enable our customers to act as registrars for their users and broker
secure communication between users on different
registries.
|
|
·
|
Leverage
our patent portfolio, technology and software to develop a suite of
products that can be sold directly to end-user
enterprises.
|
|
·
|
our
lawsuit against Microsoft;
|
|
·
|
infrastructure;
|
|
·
|
sales
and marketing;
|
|
·
|
research
and development;
|
|
·
|
personnel;
and
|
|
·
|
general
business enhancements.
|
|
·
|
our
capital resources may be
insufficient;
|
|
·
|
our
management team may not have sufficient bandwidth to successfully
capitalize on all of the opportunities identified by ipCapital
Group;
|
|
·
|
we
may not be successful in entering into licensing relationships with our
targeted customers on commercially acceptable terms;
and
|
|
·
|
the
validity of our patents underlying the licensing opportunity is currently
being challenged in our litigation against
Microsoft.
|
|
·
|
unwillingness
of consumers to shift to VoIP and use other such next-generation
Internet-based applications;
|
|
·
|
refusal
to purchase security products to secure information transmitted through
such applications;
|
|
·
|
perception
by the licensees of unsecure communication and data
transfer;
|
|
·
|
lack
of concern for privacy by licensees and
users;
|
|
·
|
limitations
on access and ease of use;
|
|
·
|
congestion
leading to delayed or extended response
times;
|
|
·
|
inadequate
development of Internet infrastructure to keep pace with increased levels
of use; and
|
·
|
increased
government
regulations.
|
|
·
|
the
need to educate potential customers about our patent rights and our
product and service capabilities;
|
|
·
|
customers’
willingness to invest potentially substantial resources and modify their
network infrastructures to take advantage of our
products;
|
|
·
|
customers’
budgetary constraints;
|
|
·
|
the
timing of customers’ budget cycles;
and
|
|
·
|
delays
caused by customers’ internal review
processes.
|
|
·
|
design,
develop, launch and/or license our planned products, services and
technologies that address the increasingly sophisticated and varied needs
of our prospective customers; and
|
|
·
|
respond
to technological advances and emerging industry standards and practices on
a cost-effective and timely
basis.
|
|
·
|
the
price of our products relative to other products that seek to secure
real-time communication;
|
|
·
|
the
perception by users of the effectiveness of our
products;
|
|
·
|
our
ability to fund our sales and marketing efforts;
and
|
|
·
|
the
effectiveness of our sales and marketing
efforts.
|
|
·
|
power
loss, transmission cable cuts and other telecommunications
failures;
|
|
·
|
damage
or interruption caused by fire, earthquake, and other natural
disasters;
|
|
·
|
computer
viruses or software defects; and
|
|
·
|
physical
or electronic break-ins, sabotage, intentional acts of vandalism,
terrorist attacks and other events beyond our
control.
|
|
·
|
substantially
greater financial, technical and marketing
resources;
|
|
·
|
a
larger customer base;
|
|
·
|
better
name recognition; and
|
|
·
|
more
expansive product offerings.
|
|
·
|
our
applications for patents, trademarks and copyrights relating to our
business may not be granted and, if granted, may be challenged or
invalidated;
|
|
·
|
issued
trademarks, copyrights, or patents may not provide us with any competitive
advantages;
|
|
·
|
our
efforts to protect our intellectual property rights may not be effective
in preventing misappropriation of our technology;
or
|
|
·
|
our
efforts may not prevent the development and design by others of products
or technologies similar to or competitive with, or superior to those we
develop.
|
|
·
|
the
need for continued development of the financial and information management
systems;
|
|
·
|
the
need to manage relationships with future licensees, resellers,
distributors and strategic
partners;
|
|
·
|
the
need to hire and retain skilled management, technical and other personnel
necessary to support and manage our business;
and
|
|
·
|
the
need to train and manage our employee
base.
|
|
·
|
challenges
caused by distance, language and cultural
differences;
|
|
·
|
legal,
legislative and regulatory
restrictions;
|
|
·
|
currency
exchange rate fluctuations;
|
|
·
|
economic
instability;
|
|
·
|
longer
payment cycles in some countries;
|
|
·
|
credit
risk and higher levels of payment
fraud;
|
|
·
|
potentially
adverse tax consequences; and
|
|
·
|
other
higher costs associated with doing business
internationally.
|
|
·
|
developments
in our litigation against
Microsoft;
|
|
·
|
large
purchases or sales of common stock;
|
|
·
|
actual
or anticipated announcements of new products or services by us or our
competitors;
|
|
·
|
general
conditions in the markets in which we compete;
and
|
|
·
|
general
economic and financial
conditions.
|
|
·
|
A staggered Board of
Directors: This means that only one or two directors
(since we have a five-person Board of Directors) will be up for election
at any given annual meeting. This has the effect of delaying
the ability of stockholders to effect a change in control of us since it
would take two annual meetings to effectively replace at least three
directors which represents a majority of the Board of
Directors.
|
|
·
|
Blank check preferred
stock: Our Board of Directors has the authority to
establish the rights, preferences and privileges of our
10,000,000 authorized, but unissued, shares of preferred
stock. Therefore, this stock may be issued at the discretion of
our Board of Directors with preferences over your shares of our common
stock in a manner that is materially dilutive to existing
stockholders. In addition, blank check preferred stock can be
used to create a “poison pill” which is designed to deter a hostile bidder
from buying a controlling interest in our stock without the approval of
our Board of Directors. We have not adopted such a “poison
pill;” but our Board of Directors has the ability to do so in the future,
very rapidly and without stockholder
approval.
|
|
·
|
Advance notice requirements for
director nominations and for new business to be brought up at stockholder
meetings: Stockholders wishing to submit director
nominations or raise matters to a vote of the stockholders must provide
notice to us within very specific date windows and in very specific form
in order to have the matter voted on at a stockholder
meeting. This has the effect of giving our Board of Directors
and management more time to react to stockholder proposals generally and
could also have the effect of disregarding a stockholder proposal or
deferring it to a subsequent meeting to the extent such proposal is not
raised properly.
|
|
·
|
No stockholder actions by
written consent: No stockholder or group of stockholders
may take actions rapidly and without prior notice to our Board of
Directors and management or to the minority stockholders. Along
with the advance notice requirements described above, this provision also
gives our Board of Directors and management more time to react to proposed
stockholder actions.
|
|
·
|
Super majority requirement for
stockholder amendments to the Bylaws: Stockholder
proposals to alter or amend our Bylaws or to adopt new Bylaws can only be
approved by the affirmative vote of at least 66 2/3% of the
outstanding shares.
|
|
·
|
Elimination of the ability of
stockholders to call a special meeting of the
stockholders: Only the Board of Directors or management
can call special meetings of the stockholders. This could mean
that stockholders, even those who represent a significant block of our
shares, may need to wait for the annual meeting before nominating
directors or raising other business proposals to be voted on by the
stockholders.
|
Securities
Beneficially Owned Prior to Offering
|
Beneficial Ownership
After the Offering
|
||||||||
Name
of selling security holder
|
Shares
of Common Stock being registered
|
Shares
of Common Stock Underlying Warrants being registered+
|
Other
Shares and Shares Underlying other Warrants
|
Total
Shares Beneficially Owned+
|
Number
of Total Shares Being Registered
|
Total
Shares Owned After Offering (1)
|
Percent
(2)
|
||
Albert
James Poliak (26)
|
-
|
37,906
|
-
|
30,575
|
37,906
|
-
|
*
|
||
Anthony
Athanas
|
39,682
|
129,195
|
22,500(3)
|
181,862
|
168,877
|
22,500
|
*
|
||
Bret
Marc Shapiro (27)
|
-
|
15,965
|
-
|
12,877
|
15,965
|
-
|
*
|
||
Capital
Ventures International (4)
|
496,032
|
1,614,956
|
-
|
1,992,064
|
2,110,988
|
-
|
*
|
||
Chad
K. Kirby
|
55,555
|
180,874
|
43,945(5)
|
267,053
|
236,429
|
43,945
|
*
|
||
Charles
Curtis
|
39,682
|
129,195
|
5,500(6)
|
164,862
|
168,877
|
5,500
|
*
|
||
Dawson
James Securities, Inc. (7)
|
-
|
57,997
|
-
|
46,781
|
57,997
|
-
|
*
|
||
Douglas
F. Kaiser (28)
|
-
|
37,906
|
-
|
30,575
|
37,906
|
-
|
*
|
||
Drs.
Robert F. & Qin C. Ryan
|
19,841
|
64,598
|
18,750(8)
|
98,431
|
84,439
|
18,750
|
*
|
||
Frank
Salvatore (29)
|
-
|
37,906
|
-
|
30,575
|
37,906
|
-
|
*
|
||
Gregory
A. Harrison
|
39,682
|
129,195
|
36,000(9)
|
195,362
|
168,877
|
36,000
|
*
|
||
Gregory
J. Wood (10)
|
63,492
|
206,715
|
1,008,000(11)
|
1,262,983
|
270,207
|
1,008,000
|
*
|
||
Gus
Blass II
|
59,523
|
193,793
|
359,900(12)
|
598,944
|
253,316
|
359,900
|
*
|
||
Hudson
Bay Fund LP (13)
|
178,572
|
581,387
|
-
|
717,145
|
759,959
|
-
|
*
|
||
Hudson
Bay Overseas Fund Ltd. (14)
|
317,459
|
1,033,568
|
-
|
1,274,915
|
1,351,027
|
-
|
*
|
||
Jay
R. Angle
|
95,238
|
310,072
|
10,000
(24)
|
392,475
|
405,310
|
10,000
|
*
|
||
Jay
R. Kuhne
|
79,365
|
258,393
|
-
|
318,729
|
337,758
|
-
|
*
|
||
John
Baleno
|
11,904
|
38,757
|
-
|
47,806
|
50,661
|
-
|
*
|
||
John
J. Blum Jr.
|
59,523
|
193,793
|
30,000
(25)
|
269,044
|
253,316
|
30,000
|
*
|
||
John
R. Rogers
|
43,650
|
142,114
|
7,500(15)
|
182,798
|
185,764
|
7,500
|
*
|
||
Joseph
Thomas Watters, III
|
39,682
|
129,195
|
11,900(16)
|
171,262
|
168,877
|
11,900
|
*
|
||
Kenneth
J. Licht
|
39,682
|
129,195
|
100,000(17)
|
259,362
|
168,877
|
100,000
|
*
|
||
Nancy
L. Schmid
|
59,523
|
193,793
|
516,574(18)
|
755,618
|
253,316
|
516,574
|
*
|
||
Peter
Wardenburg, Trustee, Wardenburg 2009 Family Trust
(19)
|
39,682
|
129,195
|
-
|
159,362
|
168,877
|
-
|
*
|
||
Ramius
Advisors, LLC (20)
|
595,237
|
1,937,943
|
-
|
2,390,471
|
2,533,180
|
-
|
*
|
||
Ramius
Enterprise Master Fund Ltd. (21)
|
178,571
|
581,383
|
-
|
717,141
|
759,954
|
-
|
*
|
||
RCG
PB Ltd. (22)
|
416,666
|
1,356,560
|
-
|
1,673,330
|
1,773,226
|
-
|
*
|
||
Robert
D. Keyser, Jr. (30)
|
-
|
37,906
|
-
|
30,575
|
37,906
|
-
|
*
|
||
Scott
E. Schalk (31)
|
-
|
40,171
|
-
|
32,402
|
40,171
|
-
|
*
|
||
Thomas
Russell Curtis
|
-
|
25,705
|
46,400(32)
|
67,134
|
25,705
|
46,400
|
*
|
||
Thomas
W. Hands (33)
|
-
|
3,720
|
-
|
3,000
|
3,720
|
-
|
*
|
||
Vestal
Venture Capital (23)
|
7,936
|
25,838
|
-
|
31,870
|
33,774
|
-
|
*
|
(1)
|
The
identified selling security holders provided us with information with
respect to their securities ownership. Because the selling
security holders may sell all, part or none of their respective shares or
other securities, we are unable to estimate the number of shares or other
securities that will be held by the selling security holders upon resale
of the securities being offered by this prospectus. We have,
therefore, assumed for the purposes of the registration statement related
to this prospectus that the selling security holders will sell all of
their securities. See “Plan of
Distribution.”
|
(2)
|
Calculated
based on Rule 13(d)-3(d)(1)(i) of the Exchange Act using 39,750,927 shares
of common stock outstanding as of September 11, 2009. In
calculating each respective selling security holder’s percentage, we did
not assume the issuance of any other shares issuable upon exercise of
outstanding warrants except for those underlying the holder’s own
derivative securities.
|
(3)
|
Warrants
to purchase 22,500 shares of common stock previously acquired by Mr.
Athanas.
|
(4)
|
Heights
Capital Management, Inc., the authorized agent of Capital Ventures
International (“CVI”), has discretionary authority to vote and dispose of
the shares held by CVI and may be deemed to be the beneficial owner of
these shares. Martin Kobinger,
in his capacity as Investment Manager of Heights Capital Management, Inc.,
may also be deemed to have investment discretion and voting power over the
shares held by CVI. Mr. Kobinger disclaims any such beneficial ownership
of the shares. CVI is not a registered broker-dealer. CVI is affiliated
with one or more registered broker-dealers. CVI purchased the shares being
registered hereunder in the ordinary course of business and at the time of
purchase, had no agreements or understandings, directly or indirectly,
with any other person to distribute such
shares.
|
(5)
|
Shares
of common stock previously acquired by Mr.
Kirby.
|
(6)
|
Includes
warrants to purchase 5,500 shares of common stock previously acquired by
Mr. Curtis.
|
(7)
|
Dawson
James is a registered broker-dealer that received a warrant to purchase
238,094 shares of common stock in connection with serving as placement
agent for the private placement transaction. The warrant is
initially exercisable for $3.93 per share. Mr. Albert J. Poliak, President
of Dawson James, has voting and investment power over these
securities. 191,313 of the initial 238,094 warrants have been
transferred to registered brokers affiliated with Dawson James who are
listed in this table as Selling Security
Holders.
|
(8)
|
Warrants
to purchase 18,750 shares of common stock previously acquired by Drs.
Robert F. & Qin C. Ryan.
|
(9)
|
Warrants
to purchase 36,000 shares of common stock previously acquired by Mr.
Harrison.
|
(10)
|
Mr.
Wood is the Senior Director of Corporate Communications of VirnetX Holding
Corporation.
|
(11)
|
Includes
908,000 shares of common stock previously acquired by Mr. Wood, 50,000
shares of common stock held in the name of The Dustan D. Sheehan
Irrevocable Trust, and 50,000 shares of common stock held in the name of
The Joshua D. Sheehan Irrevocable Trust (collectively, the
“Trusts”). Mr. Wood serves as trustee of the Trusts and
exercises voting and investment power over the shares of common stock held
by the Trusts.
|
(12)
|
Includes
269,900 shares of common stock and warrants to purchase 90,000 shares of
common stock previously acquired by Mr.
Blass.
|
(13)
|
Sander
Gerber has voting and investment power over these
securities. Sander Gerber disclaims beneficial ownership over
the securities held by Hudson Bay Fund LP. The selling
stockholder acquired the securities offered for its own account in the
ordinary course of business, and at the time it acquired the securities,
it had no agreements, plans or understandings, directly or indirectly to
distribute the securities.
|
(14)
|
Sander
Gerber has voting and investment power over these
securities. Sander Gerber disclaims beneficial ownership over
the securities held by Hudson Bay Overseas Fund Ltd. The
selling stockholder acquired the securities offered for its own account in
the ordinary course of business, and at the time it acquired the
securities, it had no agreements, plans or understandings, directly or
indirectly to distribute the
securities.
|
(15)
|
Warrants
to purchase 7,500 shares of common stock previously acquired by Mr.
Rogers.
|
(16)
|
Shares
of common stock previously acquired by Mr.
Watters.
|
(17)
|
Shares
of common stock previously acquired by Mr.
Licht.
|
(18)
|
Includes
466,574 shares of common stock previously acquired by Ms. Schmid and
50,000 shares of common stock held in the name of The Parker W. Larsen
Irrevocable Trust (the “Trust”). Ms. Schmid serves as trustee of the Trust
and exercises voting and investment power over the shares of common stock
held by the Trust.
|
(19)
|
Peter
Wardenburg, as Trustee of the Wardenburg 2009 Family Trust, has voting and
investment control over the shares of common stock and warrants held by
the Wardenburg 2009 Family Trust.
|
(20)
|
Ramius
Advisors, LLC (“Ramius Advisors”) is the investment manager of Ramius
Enterprise Master Fund Ltd (“Ramius Enterprise”) and RCG PB, Ltd. (“RCG
PB”) and consequently has voting control and investment discretion over
securities held by Ramius Enterprise and RCG PB. Ramius
Advisors did not participate directly as an investor in the Company’s
private placement transaction on September 11, 2009. The
2,533,180 shares of the Company’s common stock registered for Ramius
Advisors’ account in the selling security holder table reflect the sum of
the shares of common stock and shares of common stock underlying the
Series I Warrants, Series II Warrants and Series III Warrants held
directly by Ramius Enterprise and RCG PB, in the amounts of 759,954 and
1,773,226, respectively.
|
|
Ramius
Advisors disclaims beneficial ownership of these
securities. Ramius LLC (“Ramius”) is the managing member of
Ramius Advisors and may be considered the beneficial owner of any
securities deemed to be beneficially owned by Ramius
Advisors. Ramius disclaims beneficial ownership of these
securities. Cowen Group, Inc. (“Cowen”) is the managing member
of Ramius and may be considered the beneficial owner of any securities
deemed to be beneficially owned by Ramius. Cowen disclaims
beneficial ownership of these securities. RCG Holdings LLC
(“RCG Holdings”) is the majority shareholder of Cowen and may be
considered the beneficial owner of any securities deemed to be
beneficially owned by Cowen. RCG Holdings disclaims beneficial
ownership of these securities. C4S & Co., L.L.C. (“C4S”) is
the managing member of RCG Holdings and may be considered the beneficial
owner of any securities deemed to be beneficially owned by RCG
Holdings. C4S disclaims beneficial ownership of these
securities. Peter A. Cohen, Morgan B. Stark, Thomas W. Strauss
and Jeffrey M. Solomon are the sole managing members of C4S and may be
considered beneficial owners of any securities deemed to be beneficially
owned by C4S. Messrs. Cohen, Stark, Strauss and Solomon
disclaim beneficial ownership of these
securities.
|
|
Ramius
Advisors is not a registered broker-dealer. An affiliate of Ramius
Advisors is a registered broker-dealer. However, this affiliate
will not sell any securities purchased in this offering by Ramius
Enterprise and will receive no compensation whatsoever in connection with
sales of securities purchased in this
transaction.
|
(21)
|
Ramius
Advisors is the investment manager of Ramius Enterprise and consequently
has voting control and investment discretion over securities held by
Ramius Enterprise. Ramius Advisors disclaims beneficial
ownership of these securities. Ramius is the managing member of
Ramius Advisors and may be considered the beneficial owner of any
securities deemed to be beneficially owned by Ramius
Advisors. Ramius disclaims beneficial ownership of these
securities. Cowen Group, Inc. (“Cowen”) is the managing member
of Ramius and may be considered the beneficial owner of any securities
deemed to be beneficially owned by Ramius. Cowen disclaims
beneficial ownership of these securities. RCG Holdings LLC
(“RCG Holdings”) is the majority shareholder of Cowen and may be
considered the beneficial owner of any securities deemed to be
beneficially owned by Cowen. RCG Holdings disclaims beneficial
ownership of these securities. C4S is the managing
member of RCG Holdings and may be considered the beneficial owner of any
securities deemed to be beneficially owned by RCG Holdings. C4S
disclaims beneficial ownership of these securities. Peter A.
Cohen, Morgan B. Stark, Thomas W. Strauss and Jeffrey M. Solomon are the
sole managing members of C4S and may be considered beneficial owners of
any securities deemed to be beneficially owned by C4S. Messrs.
Cohen, Stark, Strauss and Solomon disclaim beneficial ownership of these
securities.
|
(22)
|
Ramius
Advisors is the investment manager of RCG PB, Ltd and consequently has
voting control and investment discretion over securities held by RCG
PB. Ramius Advisors disclaims beneficial ownership of these
securities. Ramius is the managing member of Ramius Advisors
and may be considered the beneficial owner of any securities deemed to be
beneficially owned by Ramius Advisors. Ramius disclaims
beneficial ownership of these securities. Cowen Group, Inc.
(“Cowen”) is the managing member of Ramius and may be considered the
beneficial owner of any securities deemed to be beneficially owned by
Ramius. Cowen disclaims beneficial ownership of these
securities. RCG Holdings LLC (“RCG Holdings”) is the majority
shareholder of Cowen and may be considered the beneficial owner of any
securities deemed to be beneficially owned by Cowen. RCG
Holdings disclaims beneficial ownership of these
securities. C4S is the managing member of RCG Holdings and may
be considered the beneficial owner of any securities deemed to be
beneficially owned by RCG Holdings. C4S disclaims beneficial
ownership of these securities. Peter A. Cohen, Morgan B. Stark,
Thomas W. Strauss and Jeffrey M. Solomon are the sole managing members of
C4S and may be considered beneficial owners of any securities deemed to be
beneficially owned by C4S. Messrs. Cohen, Stark, Strauss and
Solomon disclaim beneficial ownership of these
securities.
|
(23)
|
Allan
R. Lyons, as managing member of the managing general partner of Vestal
Venture Capital, has voting and investing control over the shares held by
Vestal Venture Capital. Vestal Venture Capital is not a
registered broker-dealer. Vestal Venture Capital is an
affiliate of a registered
broker-dealer.
|
(24)
|
Shares of common stock previously acquired by Mr.
Angle.
|
(25)
|
Includes warrants to purchase 15,000 shares of common stock
and 15,000 shares of common stock previously acquired by Mr.
Blum.
|
(26)
|
Mr. Poliak is a registered broker-dealer and is affiliated
with Dawson James Securities,
Inc.
|
(27)
|
Mr. Shapiro is a registered broker-dealer and is affiliated
with Dawson James Securities,
Inc.
|
(28)
|
Mr. Kaiser is a registered broker-dealer and is affiliated
with Dawson James Securities,
Inc.
|
(29)
|
Mr. Salvatore is a registered broker-dealer and is
affiliated with Dawson James Securities,
Inc.
|
(30)
|
Mr. Keyser is a registered broker-dealer and is affiliated
with Dawson James Securities,
Inc.
|
(31)
|
Mr. Schalk is a registered broker-dealer and is affiliated
with Dawson James Securities,
Inc.
|
(32)
|
Shares of common stock previously acquired by Mr.
Curtis. Mr. Curtis is a registered broker-dealer and is
affiliated with Dawson James Securities,
Inc.
|
(33)
|
Mr. Hands is a registered broker-dealer and is affiliated
with Dawson James Securities,
Inc.
|
|
|
·
|
ordinary
brokerage transactions and transactions in which the broker-dealer
solicits purchasers;
|
|
·
|
block
trades in which the broker-dealer will attempt to sell the shares as agent
but may position and resell a portion of the block as principal to
facilitate the transaction;
|
|
·
|
purchases
by a broker-dealer as principal and resale by the broker-dealer for its
account;
|
|
·
|
an
exchange distribution in accordance with the rules of the applicable
exchange;
|
|
·
|
privately
negotiated transactions;
|
|
·
|
settlement
of short sales entered into after the effective date of the registration
statement of which this prospectus is a
part;
|
|
·
|
in
transactions through broker-dealers that agree with the selling security
holders to sell a specified number of such shares at a stipulated price
per share;
|
|
·
|
through
the writing or settlement of options or other hedging transactions,
whether through an options exchange or
otherwise;
|
|
·
|
a
combination of any such methods of sale;
or
|
|
·
|
any
other method permitted pursuant to applicable
law.
|
|
●
|
The
Series I Warrants give the investors in the transaction rights to
purchase the same number of shares purchased in the transaction over
a 5-year term at an exercise price equal to 125% of the price per share
paid in the transaction, subject to anti-dilution protection that
could reduce the exercise price; provided however, that in no event shall
such exercise price be reduced to less than $3.17 (the closing price per
share of our common stock) subject to adjustments for reverse and forward
stock splits, stock dividends, stock combinations and other similar
transactions affecting the Company’s common stock. The Series I Warrants
are not exercisable until March 11, 2010 and expire on March 11,
2015. Aside from the anti-dilution adjustment associated with
the exercise price premium, the Series I Warrants are not subject to any
further adjustments with respect to the exercise price or number of shares
covered. The aggregate number of shares of common stock
registered by this prospectus includes 627,907 shares of our common stock
issuable pursuant to the anti-dilution protection provisions
described above. We will not receive proceeds from any shares
issued pursuant to the anti-dilution protection
provisions.
|
|
●
|
The
Series II Warrants give the investors in the transaction pricing
protection for the transaction with a floor price of $1.25 per
share. In the event the market price of our common stock
declines between the closing of the transaction and the earlier of (i) 15
business days after the date this Registration Statement is declared
effective and (ii) the date Rule 144 becomes available for resale of the
common stock registered pursuant to this prospectus (such date that is the
earlier of clause (i) and (ii) is referred to in this registration
statement as the “Warrant Exercise Date”), the Series II Warrants will be
automatically exercised on a cashless exercise basis and a number of
additional shares will be issued to the investors in order to effectively
reduce the per share purchase price paid in the private placement
transaction to the greater of (i) 80% of the 15-day volume weighted
average trading price per share of our common stock immediately prior to
the Warrant Exercise Date and (ii) $1.25 per share. At the
Warrant Exercise Date, the Series II Warrants will either be automatically
exercised on a cashless exercise basis if our stock price is lower at the
Warrant Exercise Date as described above, or they will terminate
unexercised. The adjustment associated with the Series II
Warrants does not affect either the exercise price or number of shares
covered by either the Series I Warrants or the Series III
Warrants.
|
|
●
|
At
the Warrant Exercise Date, the Series III Warrants give the investors in
the transaction a 60-day right to purchase an additional $6.0 million
of our common stock at $2.52 per share. The Series III Warrants
are not subject to any adjustments with respect to the exercise price or
number of shares covered.
|
Series I
Warrants
|
Series II
Warrants
|
Series III
Warrants
|
|
Number of shares issuable upon exercise of
warrants
|
3,246,959
|
2,419,045
|
2,380,942
|
Time frame during which the warrants can be
exercised (1)
|
The Series I Warrants are exercisable commencing on March
11, 2010 and ending on March 11, 2015.
|
At the Warrant Exercise Date (as defined above), the Series
II Warrants will either be automatically exercised on a cashless exercise
basis if our stock price is lower at the Warrant Exercise Date as
described above, or they will terminate
unexercised.
|
At the Warrant Exercise Date, the Series III Warrants give
the investors in the transaction a 60-day right to purchase an additional
$6.0 million of our common stock at $2.52 per
share.
|
Percentage of shares currently outstanding represented by
the shares underlying each series of warrant (1)
|
8.2%
|
6.1%
|
6.0%
|
Economic effect of exercise of warrants on existing
stockholders (2)
|
n/a (3)
|
$1.93 (4)
|
n/a (3)
|
|
·
|
A staggered Board of
Directors: this means that only one or two directors
(since we have a five person Board of Directors) will be up for election
at any given annual meeting. This has the effect of delaying the ability
of stockholders to effect a change in control of the Board of Directors
since it will take two annual meetings to effectively replace at least
three directors which represents a majority of the Board of
Directors.
|
|
·
|
Blank check preferred
stock: our Board of Directors has the authority to
establish the rights, preferences and privileges of our 10,000,000
authorized but unissued shares of preferred stock. Therefore, this stock
may be issued at the discretion of our Board of Directors with preferences
over your shares of common stock in a manner that is materially dilutive
to exiting stockholders. In addition, blank check preferred stock can be
used to create a “poison pill” which is designed to deter a hostile bidder
from buying a controlling interest in our stock without the approval of
our Board of Directors. We have not adopted such a “poison pill,” but our
Board of Directors will have the ability to do so in the future very
rapidly and without stockholder
approval.
|
|
·
|
Advance notice requirements
for director nominations and for new business to be brought up at
stockholder meetings: stockholders wishing to submit
director nominations or raise matters to a vote of the stockholders must
provide notice to us within very specific date windows in order to have
the matter voted on at the meeting. This has the effect of giving our
Board of Directors and management more time to react to stockholder
proposals generally and could also have the effect of delaying a
stockholder proposal to a subsequent meeting to the extent such proposal
is not raised in a timely manner for an upcoming
meeting.
|
|
·
|
Elimination of stockholder
actions by written consent: this has the effect of
eliminating the ability of a stockholder or a group of stockholders
representing a majority of the outstanding shares to take actions rapidly
and without prior notice to our Board of Directors and management or to
the minority stockholders. Along with the advance notice requirements
described above, this provision also gives our Board of Directors and
management more time to react to proposed stockholder
actions.
|
|
·
|
Super majority requirement for
stockholder amendments to the By-laws: our By-laws may
be altered or amended or new By-laws adopted by the affirmative vote of at
least 66-2/3% of the outstanding shares. This has the effect of requiring
a substantially greater vote of the stockholders to approve any changes to
our By-laws.
|
|
·
|
Elimination of the ability of
stockholders to call a special meeting of the
stockholders: only the Board of Directors or management
can call special meetings of the stockholders. This could mean that
stockholders, even those who represent a significant block of shares, may
need to wait for the annual meeting before nominating directors or raising
other business proposals to be voted on by the
stockholders.
|
|
·
|
our
Annual Report on Form 10-K for the year ended December 31,
2008;
|
|
·
|
our
Quarterly Reports on Form 10-Q for the period ended March 31, 2009 and
June 30, 2009;
|
|
·
|
our
definitive Proxy Statement on Schedule 14A, dated and filed with the SEC
on April 28, 2009 for our 2009 Annual Meeting of
Stockholders;
|
|
·
|
our
Current Reports on Form 8-K filed with the SEC on April 8, 2009, May
5, 2009, June 11, 2009, June 29, 2009, and September 3, 2009;
and
|
|
·
|
the
description of our capital stock contained in the Registration Statement
on Form SB-2 filed with the SEC on March 26, 1999, including any amendment
or reports filed for the purpose of updating that
description.
|
Amount to be
Paid
|
||||
SEC
registration fee
|
$
|
1,550.70 **
|
||
Legal
fees and expenses
|
$
|
20,000
|
||
Accounting
fees and expenses
|
$
|
12,000
|
||
Miscellaneous
|
$
|
10,000
|
||
Total
|
$
|
43,550.70
|
(i)
|
To
include any prospectus required by Section 10(a)(3) of the Securities Act
of 1933;
|
(ii)
|
To
reflect in the prospectus any facts or events arising after the effective
date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from
the low or high end of the estimated maximum offering range may be
reflected in the form of prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price
represent no more than 20 percent change in the maximum aggregate offering
price set forth in the “Calculation of Registration Fee” table in the
effective registration
statement;
|
(iii)
|
To
include any material information with respect to the plan of distribution
not previously disclosed in the registration statement or any material
change to such information in the registration
statement;
|
(i)
|
Any
preliminary prospectus or prospectus of the undersigned registrant
relating to the offering required to be filed pursuant to
Rule 424;
|
(ii)
|
Any
free writing prospectus relating to the offering prepared by or on behalf
of the undersigned registrant or used or referred to by the undersigned
registrant;
|
(iii)
|
The
portion of any other free writing prospectus relating to the offering
containing material information about the undersigned registrant or its
securities provided by or on behalf of the undersigned registrant;
and
|
(iv)
|
Any
other communication that is an offer in the offering made by the
undersigned registrant to the
purchaser.
|
VIRNETX HOLDING
CORPORATION
|
|||
By:
|
/s/
Kendall Larsen
|
||
Name: Kendall
Larsen
|
|||
Title: President
and Chief Executive Officer
|
|||
Signature and
Name
|
Capacity
|
Date
|
|
/s/ Kendall
Larsen
Kendall Larsen
|
President, Chief Executive Officer
(Principal Executive Officer), Director, and
Attorney-in-Fact
|
November 6, 2009
|
|
/s/ William E.
Sliney*
William E. Sliney
|
Chief Financial Officer (Principal
Accounting and Financial Officer)
|
November 6, 2009
|
|
/s/ Edmund C.
Munger*
Edmund C. Munger
|
Director
|
November 6, 2009
|
|
/s/ Scott C.
Taylor*
Scott C. Taylor
|
Director
|
November 6, 2009
|
|
/s/ Michael F.
Angelo*
Michael F. Angelo
|
Director
|
November 6, 2009
|
|
/s/ Thomas M.
O’Brien*
Thomas M. O’Brien
|
Director
|
November 6, 2009
|
|
3.1
|
Amended
and Restated Certificate of Incorporation of the Company
(1)
|
3.2
|
Amended
and Restated Bylaws of the Company (2)
|
4.1
|
Form
of Series I Warrant attached as Exhibit C-I to the Securities Purchase
Agreement dated September 2, 2009 (3)
|
4.2
|
Form
of Series II Warrant attached as Exhibit C-II to the Securities Purchase
Agreement dated September 2, 2009 (4)
|
4.3
|
Form
of Series III Warrant attached as Exhibit C-III to the Securities Purchase
Agreement dated September 2, 2009 (5)
|
4.4
|
Registration
Rights Agreement dated as of September 2, 2009 by and between VirnetX
Holding Corporation and each of the several purchasers signatory thereto
(6)
|
4.5
|
Securities
Purchase Agreement, dated September 2, 2009, by and between VirnetX
Holding Corporation and each purchaser identified on the signature pages
thereto (7)
|
5.1
|
Opinion
of Orrick, Herrington & Sutcliffe LLP
|
23.2
|
Consent
of Farber Hass Hurley & McEwen, LLP, Independent
Auditors
|
23.2
|
Consent
of Orrick, Herrington & Sutcliffe LLP (contained in
Exhibit 5.1)
|
24.1
|
Power
of Attorney (contained in the signature pages
hereto)
|
(1)
|
Incorporated
by reference to Exhibit 3.1 the Company’s Form 8-K (Commission File
No. 001-33852) filed with the Securities and Exchange Commission on
November 1, 2007.
|
|
(2)
|
Incorporated
by reference to Exhibit 3.2 the Company’s Form 8-K (Commission File
No. 001-33852) filed with the Securities and Exchange Commission on
November 1, 2007.
|
|
(3)
|
Incorporated
by reference to Exhibit 4.1 to the Company’s Form 8-K (Commission
File No. 001-33852) filed with the Securities and Exchange Commission on
September 3, 2009.
|
|
(4)
|
Incorporated
by reference to Exhibit 4.2 to the Company’s Form 8-K (Commission
File No. 001-33852) filed with the Securities and Exchange Commission on
September 3, 2009.
|
|
(5)
|
Incorporated
by reference to Exhibit 4.3 to the Company’s Form 8-K (Commission
File No. 001-33852) filed with the Securities and Exchange Commission on
September 3, 2009.
|
|
(6)
|
Incorporated
by reference to Exhibit 10.2 to the Company’s Form 8-K (Commission
File No. 001-33852) filed with the Securities and Exchange Commission on
September 3, 2009.
|
|
(7)
|
Incorporated
by reference to Exhibit 10.1 to the Company’s Form 8-K (Commission
File No. 001-33852) filed with the Securities and Exchange Commission on
September 3, 2009.
|
|
ORRICK,
HERRINGTON & SUTCLIFFE LLP
THE
ORRICK BUILDING
405
HOWARD STREET
SAN
FRANCISCO, CALIFORNIA 94105-2669
tel +1-415-773-5700
fax +1-415-773-5759
www.orrick.com
|
VirnetX
Holding Corporation
5615
Scotts Valley Drive, Suite 110
Scotts
Valley, California 95066
|
|
Re:
|
Registration
Statement on Form S-3
|
Very
truly yours,
/s/
Orrick, Herrington & Sutcliffe LLP
Orrick,
Herrington & Sutcliffe
LLP
|